iRhythm Holdings

iRhythm Holdings announced a definitive agreement to acquire VitalConnect for approximately $287.5 million ($237.5 million cash + $50 million stock). VitalConnect provides FDA-cleared wearable biosensor and cardiac monitoring technology.